RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/34699325http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34699325http://www.w3.org/2000/01/rdf-schema#comment"Colorectal cancer (CRC) is a global public health issue with increasing prevalence. MicroRNA-934 (miR-934) is a kind of non-coding RNA involved in the regulation of diverse cancers. Though previous researches have revealed part of association between miR-934 and CRC, the role of miR-934 in CRC pathogenesis has not been completely explored yet. In this study, we aim to investigate the effect of miR-934 on cell proliferation, migration, invasion and angiogenesis in CRC. Accordingly, miR-934 was found to be over-expressed in SW480 and HCT116 cells, two typical CRC cell lines. Meanwhile, miR-934 knockdown significantly inhibited cell proliferation and induced cell cycle arrest in SW480 and HCT116 cells. It was further validated that miR-934 knockdown displayed an inhibitory effect on cell migration and invasion in SW480 and HCT116 cells. Additionally, miR-934 deficiency markedly decreased VEGF expression in SW480 and HCT116 cells and suppressed capability of CRC cells to promote tube formation in vascular endothelial cells, which suggests the pro-angiogenesis role of miR-934 in vitro. Dual luciferase reporter assay further showed that miR-934 directly bound to B-cell translocation gene 2 (BTG2). BTG2 knockdown reversed the inhibitory effect of miR-934 silencing on cell proliferation, migration, invasion, and angiogenesis in SW480 and HCT116 cells. In summary, this study suggests that miR-934 facilitates CRC progression by targeting BTG2, and further highlights the role of miR-934 in pathogenesis of CRC."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.org/dc/terms/identifier"doi:10.1080/21655979.2021.1996505"xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/author"Liu X."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/author"Li B."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/author"Liu J."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/author"Liu J.'"xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/author"Wu G."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/author"Wang F."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/author"Yang C."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/author"Cai S."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/name"Bioengineered"xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/pages"9507-9519"xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/title"MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2."xsd:string
http://purl.uniprot.org/citations/34699325http://purl.uniprot.org/core/volume"12"xsd:string
http://purl.uniprot.org/citations/34699325http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/34699325
http://purl.uniprot.org/citations/34699325http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/34699325
http://purl.uniprot.org/uniprot/#_P78543-mappedCitation-34699325http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34699325
http://purl.uniprot.org/uniprot/P78543http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/34699325